Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Alnylam Pharmaceuticals Inc.
said Monday it would no longer pursue its supplemental new drug application for patisiran as a treatment for the cardiomyopathy of transthyretin-mediated amyloidosis after receiving a complete response letter from the U.S. Food and Drug Administration. Patisiran is already approved for the treatment of the polyneuropathy of hereditary ATTR amyloidosis in adults. The CRL, which means the FDA cannot approve the sNDA for now, does not impact the other indication.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Best Buy to start offering a continuous glucose monitoring system for diabetics, it’s first prescription-based medical deviceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »
ABC 10News Pinpoint Weather for Sun. October 8, 2023: Foggy start along the coast, cool down on the wayCiara Encinas joined the ABC 10News team in December 2021 as a multimedia journalist.
Read more »
ABC 10News Pinpoint Weather for Sat. October 7, 2023: Foggy start along coast, another warm day inlandCiara Encinas joined the ABC 10News team in December 2021 as a multimedia journalist.
Read more »
The Best Beauty Instagrams of the Week: Ciara, Troye Sivan, and MoreThis week's best beauty Instagrams presented glamour in all forms.
Read more »
FDA-approved injection can restore collagen and improve aging signsThe Food and Drug Administration has approved an easy and effective method of restoring collagen in the skin without having to ingest endless supplements.
Read more »
FDA: Blood Pressure Medication Recall After Oxycodone FoundI am a writer, journalist, professor, systems modeler, computational, AI, and digital health expert, medical doctor, avocado-eater, and entrepreneur, not always in that order. Currently, I am a Professor of Health Policy and Management at the City University of New York (CUNY) School of Public Health, Executive Director of PHICOR (PHICORteam) and Center for Advanced Technology and Communication in Health (CATCH), and founder and CEO of Symsilico. My previous positions include serving as Profess
Read more »